Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects.

CONTEXT The mechanisms underlying weight loss after Roux-en-Y gastric bypass (RYGBP) are not well understood. OBJECTIVE The objective of the study was to assess the changes in active glucagon-like peptide 1 (GLP-1) and total peptide YY (PYY) after RYGBP and examine their relationship with changes in hunger and satiety. DESIGN This was a prospective study on the changes in active GLP-1, PYY, hunger, and satiety in response to a standardized test meal in nine normal-glucose-tolerant obese subjects [body mass index (BMI) 47.4 +/- 6.1 kg/m(2)] before and 6 wk after RYGBP. RESULTS Before surgery, meal ingestion failed to stimulate GLP-1 and PYY secretion. Six weeks after surgery, despite subjects still being markedly obese (BMI 43.6 +/- 7.8 kg/m(2)), the area under the curve(0-120') of GLP-1 and of PYY in response to the standardized test meal were significantly elevated (P < 0.05 and P < 0.01, respectively). These hormonal responses were significantly larger (P < 0.01) than those observed in a group matched for the BMI attained 6 wk after surgery. The 2.9 +/- 1.2- and 1.6 +/- 1.9-fold increase, respectively, in the area under the curve(0-120') of GLP-1 and PYY were accompanied by a significant decrease in fasting (P < 0.05) and postprandial hunger (P = 0.05) and a significant increase in satiety (P < 0.05) after meal intake. Nevertheless, a significant correlation between changes in the hormonal and eating behavior parameters was not found. CONCLUSION Our data show that RYGBP is associated with an improvement in the active GLP-1 and total PYY response to a liquid-meal intake. Moreover, we provide circumstantial evidence for a potential role of these gastrointestinal hormones on the decreased appetite after RYGBP.

[1]  M. Nauck,et al.  Glucagon‐like peptide 1(GLP‐1) in biology and pathology , 2005, Diabetes/metabolism research and reviews.

[2]  P. Shekelle,et al.  Meta-Analysis: Surgical Treatment of Obesity , 2005, Annals of Internal Medicine.

[3]  M. Horowitz,et al.  Gastric emptying after gastric bypass. , 1986, International journal of obesity.

[4]  M. Bessler,et al.  Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin. , 2005, The Journal of clinical endocrinology and metabolism.

[5]  S. Woods,et al.  Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats. , 2005, American journal of physiology. Endocrinology and metabolism.

[6]  A. Stunkard,et al.  Appetitive behavior after gastric bypass for obesity. , 1981, International journal of obesity.

[7]  S. Toubro,et al.  The role of postprandial releases of insulin and incretin hormones in meal-induced satiety—effect of obesity and weight reduction , 2001, International Journal of Obesity.

[8]  T. Reinehr,et al.  Peptide YY is a regulator of energy homeostasis in obese children before and after weight loss. , 2005, The Journal of clinical endocrinology and metabolism.

[9]  V. Marks,et al.  Attenuated GLP-1 secretion in obesity: cause or consequence? , 1996, Gut.

[10]  S. Aylwin Gastrointestinal surgery and gut hormones , 2005 .

[11]  J. Holst,et al.  Gastrointestinal hormones and gastric emptying 20 years after jejunoileal bypass for massive obesity , 1997, International Journal of Obesity.

[12]  Husebye,et al.  Delay of gastric emptying by duodenal intubation: sensitive measurement of gastric emptying by the paracetamol absorption test , 1999, Alimentary pharmacology & therapeutics.

[13]  J. Flier,et al.  The Gut and Energy Balance: Visceral Allies in the Obesity Wars , 2005, Science.

[14]  J. Saebel,et al.  Eating Behavior and the Experience of Hunger Following Gastric Bypass Surgery for Morbid Obesity , 1997, Obesity surgery.

[15]  I. Näslund,et al.  Gastric emptying rate after gastric bypass and gastroplasty. , 1987, Scandinavian journal of gastroenterology.

[16]  J. A. Fernández-Represa,et al.  Peptide YY Secretion in Morbidly Obese Patients Before and After Vertical Banded Gastroplasty , 2002, Obesity surgery.

[17]  R. Whelpton,et al.  A model of gastric emptying using paracetamol absorption in intensive care patients , 1997, Intensive Care Medicine.

[18]  A. Astrup,et al.  The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity , 2001, International Journal of Obesity.

[19]  R. Batterham,et al.  Gut Hormone Profiles Following Bariatric Surgery Favor an Anorectic State, Facilitate Weight Loss, and Improve Metabolic Parameters , 2006, Annals of surgery.

[20]  A. Lacy,et al.  Short-term effects of gastric bypass surgery on circulating ghrelin levels. , 2004, Obesity research.

[21]  E. Dellinger,et al.  Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. , 2002, The New England journal of medicine.

[22]  Mohammad A Ghatei,et al.  Inhibition of food intake in obese subjects by peptide YY3-36. , 2003, The New England journal of medicine.

[23]  D. Martin,et al.  Gastrointestinal hormone responses to meals before and after gastric bypass and vertical banded gastroplasty. , 1990, Annals of surgery.

[24]  R. Brolin,et al.  Bariatric surgery and long-term control of morbid obesity. , 2002, JAMA.

[25]  J. Dixon,et al.  Laparoscopic adjustable gastric banding induces prolonged satiety: a randomized blind crossover study. , 2005, The Journal of clinical endocrinology and metabolism.

[26]  Claude Bouchard,et al.  Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. , 2004, The New England journal of medicine.

[27]  R. Zabielski,et al.  Multiple regulation of peptide YY secretion in the digestive tract , 2002, Peptides.

[28]  S. Woods,et al.  Food intake and the regulation of body weight. , 2000, Annual review of psychology.

[29]  G. Sciarretta,et al.  Lactulose hydrogen breath test in orocecal transit assessment , 1994, Digestive Diseases and Sciences.

[30]  G. Wittert,et al.  Hormonal Changes after Roux-en Y Gastric Bypass for Morbid Obesity and the Control of Type-II Diabetes Mellitus , 2004, The American surgeon.

[31]  M. Gagner,et al.  The Early Effect of the Roux-en-Y Gastric Bypass on Hormones Involved in Body Weight Regulation and Glucose Metabolism , 2004, Annals of surgery.

[32]  T. Adrian,et al.  Release of peptide YY (PYY) after resection of small bowel, colon, or pancreas in man. , 1987, Surgery.

[33]  Rachel L. Batterham,et al.  Gut hormone PYY3-36 physiologically inhibits food intake , 2002, Nature.

[34]  A. Astrup,et al.  A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans. , 2001, The Journal of clinical endocrinology and metabolism.

[35]  D. Cummings,et al.  Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution. , 2004, The Journal of clinical endocrinology and metabolism.

[36]  S. Bloom,et al.  Why do patients lose weight after Roux-en-Y gastric bypass? , 2005, The Journal of clinical endocrinology and metabolism.

[37]  E. Straus,et al.  Pancreatic polypeptide, pancreatic glucagon and enteroglucagon in morbid obesity and following gastric bypass operation. , 1986, International journal of obesity.